Ildren with high-risk neuroblastoma treated on a randomized trial of myeloablative therapy followed by PARP
Ildren with high-risk neuroblastoma treated on a randomized trial of myeloablative therapy followed by PARP Inhibitor Storage & Stability 13-cis-retinoic acid: a children's oncology group study. J Clin Oncol. 2009;27(7):1007013.…